STRATEC CONSUMABLES GMBH

Their core work

STRATEC Consumables GmbH is an Austrian manufacturer of precision lab consumables, microfluidic devices, and biochip cartridges — the physical components that diagnostic instruments and analytical platforms need to run assays. Part of the broader STRATEC group, they specialize in translating laboratory assay concepts into manufacturable consumable form factors, including flow cells, microfluidic channels, and integrated cartridges. In EU projects, they serve as the manufacturing and industrial integration partner, contributing production know-how that moves prototype biophotonic or immunological assay platforms toward commercially viable diagnostic products. Their value to research consortia is bridging the gap between laboratory science and scalable, reproducible consumable production.

What they specialise in

How they've shifted over time

STRATEC Consumables entered H2020 in 2016 with COBIOPHAD, a project squarely in biophotonic diagnostics and point-of-care device development — an area closely aligned with their core consumables manufacturing business. The following year they joined EN_ACTI2NG, an MSCA training network in cancer immunotherapy, suggesting an expansion from device-focused diagnostics toward biological research support tools. However, with only two projects spanning an overlapping four-year window and no keyword data available, it is difficult to confirm a meaningful strategic shift; the two participations may simply reflect opportunistic consortium invitations rather than a deliberate reorientation.

Based on two projects, STRATEC Consumables appears to be selectively expanding from pure diagnostics consumables toward broader biomedical research support, but the sample is too small to call this a firm direction.

How they like to work

STRATEC Consumables participates exclusively as a consortium partner — they have never led an H2020 project — which is typical for industrial manufacturers who contribute specific components or production capabilities rather than scientific coordination. With 24 unique partners across just 2 projects, they operate in relatively large, diverse consortia (averaging 12 partners per project), suggesting they are comfortable in complex multi-partner environments. This profile indicates a company that is a reliable industrial contributor sought out for specific manufacturing expertise, not a scientific driver or project architect.

STRATEC Consumables has worked with 24 unique consortium partners across 8 countries, a broad reach for only two projects, reflecting the large international consortia typical of biophotonics and immunotherapy training networks. No single country dominates the collaboration footprint, suggesting genuine European-wide engagement rather than a regional cluster.

What sets them apart

STRATEC Consumables fills a rare niche: an established industrial manufacturer that can take a laboratory-proven assay concept and produce the physical consumable — cartridge, flow cell, biochip — at quality and scale that academic partners cannot. Where most H2020 health consortia struggle to find an industrial partner willing to handle precision plastics, microfluidics fabrication, and regulatory-grade quality systems, STRATEC brings all three under one roof. For a consortium targeting a TRL 5–7 diagnostic device or research platform, their presence significantly improves the credibility of the commercialization pathway.

Highlights from their portfolio

• COBIOPHAD
  As an Innovation Action (the highest-TRL H2020 instrument), COBIOPHAD aimed directly at a market-ready compact diagnostic platform — STRATEC's largest single grant (EUR 304,098) and the clearest signal of their role in translating photonics research into manufacturable diagnostic consumables.
• EN_ACTI2NG
  An MSCA Innovative Training Network in CAR-T and TCR cancer immunotherapy, this project marks STRATEC's entry into the oncology research tools space, broadening their portfolio beyond diagnostics into cutting-edge cell therapy research infrastructure.